10X Genomics Inc (Class A)

28 Sept 2026, 20:07 UTC

10X Genomics Inc shares are higher as Piper Sandler raises its price target to $80 and Argus initiates coverage with a Buy rating and $110 target.

25 Sept 2026, 20:08 UTC

10X Genomics Inc is advancing amid a broader market rally, reflecting strong performance and positioning well above its 20-day moving average.

24 Sept 2026, 23:01 UTC

10X Genomics Inc is trading higher in after-market hours, recovering from an initial dip and benefiting from broader market strength.

23 Sept 2026, 20:02 UTC

10X Genomics Inc shares fell sharply on Wednesday, breaking a recent trend of higher daily closes amid unusually high market volume.

22 Sept 2026, 20:07 UTC

10X Genomics Inc is advancing during Tuesday's session, supported by positive social media sentiment and remaining above its 20-day moving average.

21 Sept 2026, 23:06 UTC

10X Genomics Inc saw routine after-market trading with price movement remaining roughly flat, following a strong one-month performance above its 20-day moving average.

18 Sept 2026, 19:16 UTC

10X Genomics Inc shares fell sharply, retracing from an earlier high, despite remaining above the 20-day moving average and near the upper end of its one-month range.

17 Sept 2026, 23:06 UTC

10X Genomics Inc has seen modest gains in after-market trading, remaining significantly above its 20-day moving average and near the upper end of its one-month range.

16 Sept 2026, 19:22 UTC

10X Genomics Inc shares fell sharply during Wednesday's trading session after an initial gain, reflecting notable volatility and a decline since Tuesday's close.

15 Sept 2026, 23:02 UTC

10X Genomics Inc shares are higher in after-market trading, reflecting overall positive market sentiment despite recent declines in manufacturing and rising crude oil inventories.

14 Sept 2026, 23:06 UTC

10X Genomics Inc. shares are lower in after-market trading, aligning with a broader U.S. market decline amid rising crude oil prices due to supply concerns.

11 Sept 2026, 20:08 UTC

10X Genomics Inc. is rising today, supported by positive social media sentiment and strong trading momentum above key moving averages.

10 Sept 2026, 23:26 UTC

10X Genomics shares advanced in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

9 Sept 2026, 19:56 UTC

UBS raised its price target for 10X Genomics to $68, maintaining a Neutral rating. The stock is trading higher amid positive social media discussions.

8 Sept 2026, 20:07 UTC

10X Genomics raises 2026 revenue guidance to $610 million-$630 million, driving shares higher during trading. Analysts express concerns about potential overvaluation.

2 Sept 2026, 20:08 UTC

10X Genomics Inc. shares are higher today, driven by significant gains in the Life Sciences Tools & Services sub-sector. No specific company news was identified.

1 Sept 2026, 20:04 UTC

10X Genomics Inc shares are lower after RBC Capital initiated coverage with a Sector Perform rating and a $70 price target. Rising oil prices add to inflation concerns.

31 Aug 2026, 20:07 UTC

10X Genomics awarded over $4.8 million in damages by jury for patent infringement. Analysts see potential for favorable outcomes, boosting shares higher today.

28 Aug 2026, 23:46 UTC

10X Genomics Inc is trading higher in after-market hours, reflecting positive market performance amid rising Treasury yields and increased rate hike expectations.

26 Aug 2026, 19:36 UTC

10X Genomics Inc shares are lower today, reaching a session low earlier. Broader inflation data may impact Federal Reserve policy decisions.

25 Aug 2026, 23:21 UTC

10X Genomics Inc shares are higher in after-market hours, though no specific news was identified. Market sentiment improved amid a decline in crude oil prices.

24 Aug 2026, 19:26 UTC

10X Genomics Inc shares are lower today amid broader market declines and geopolitical tensions, though the stock remains significantly above its 20-day moving average.

21 Aug 2026, 23:16 UTC

10X Genomics Inc. shares are higher in after-market trading, continuing gains since Friday's close, amid broader cryptocurrency market strength.

20 Aug 2026, 23:16 UTC

10X Genomics Inc. shares traded lower after-market, amid broader market pressure from rising bond yields and concerns over high borrowing costs and geopolitical risks.

19 Aug 2026, 23:06 UTC

10X Genomics Inc shares are higher in after-market trading, reflecting strong momentum above the 20-day moving average and near the top of its one-month range.

18 Aug 2026, 23:31 UTC

10X Genomics Inc shares are higher in after-market trading, maintaining a notable increase while staying above the 20-day moving average. No specific news was identified.

17 Aug 2026, 19:16 UTC

10X Genomics Inc shares are higher today, recovering from an initial dip. The stock remains above its 20-day moving average amid mixed economic indicators.

14 Aug 2026, 20:06 UTC

10X Genomics Inc shares are lower today amid mixed market sentiment following a reported decline in U.S. retail sales for July.

13 Aug 2026, 19:16 UTC

10X Genomics Inc reported Q2 revenue of $151 million, exceeding estimates. Shares are higher as management raises full-year revenue guidance to $620 million.

12 Aug 2026, 19:46 UTC

10X Genomics Inc. shares are lower today, having retraced from an early peak. The stock remains above its 20-day moving average.